Genetics - Adult | Mental Health & Behavioral Research, Phase III

EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

Volunteers
Health Professionals

What is the purpose of this trial?

To evaluate the proportion of obese patients who respond to setmelanotide at 52 weeks of treatment.

Trial with
Rhythm Pharmaceuticals, Inc.
Ages
6 years - 65 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact YWeight

yweight@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Ania Jastreboff, MD, PhD
Associate Professor of Medicine (Endocrinology); Director, Yale Obesity Research Center (Y-Weight); Co-Director, Yale Center for Weight Management; Medical Director, Yale Stress Center

Sub-Investigator

Jennifer Cannon

Last Updated
10/16/2024
Study HIC
#2000032942